{"gene":"S100A3","run_date":"2026-06-10T07:46:28","timeline":{"discoveries":[{"year":1993,"finding":"S100A3 (S100E) is a cysteine-rich calcium-binding protein encoded within a tight cluster of six S100 genes on human chromosome 1q21, distinguishing it from other S100 family members by its unusually high cysteine content.","method":"Pulsed-field gel electrophoresis, genomic sequencing, chromosomal mapping","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct genomic/sequencing characterization identifying unique structural feature, single study with clear experimental evidence","pmids":["8341667"],"is_preprint":false},{"year":1998,"finding":"S100A3 exists as a non-covalently bound dimer and binds Ca2+ with low affinity (Kd ~4 mM) and Zn2+ with high affinity via its cysteine residues, forming dinuclear thiolate-bridged metal clusters involving (Cys)4 and (Cys)3(His) coordination sites analogous to zinc finger proteins.","method":"Anaerobic recombinant protein purification, spectrophotometric metal titration, size exclusion chromatography, CD spectroscopy","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro biochemical characterization with multiple spectroscopic methods, single lab","pmids":["9920417"],"is_preprint":false},{"year":2002,"finding":"Crystal structure of metal-free S100A3 at 1.7 Å resolution revealed a large distortion of the C-terminal canonical EF-hand that likely abolishes Ca2+ binding, and identified a putative Zn2+-binding site in the C-terminus involving Cys and His residues; Zn2+ binding induces large conformational changes perturbing the hydrophobic dimer interface.","method":"X-ray crystallography (1.7 Å), size exclusion chromatography, CD spectroscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with functional validation by SEC and CD, replicated by subsequent structural studies","pmids":["12045193"],"is_preprint":false},{"year":2002,"finding":"Metal-free apo-S100A3 crystal structure confirmed the overall fold resembles metal-free S100B and S100A6, with well-ordered EF-hand loops; in the N-terminal pseudo-EF-hand loop a water molecule occupies the Ca2+ position, and the C-terminal canonical EF-hand shows extended conformation distinct from metal-bound S100 structures.","method":"X-ray crystallography solved by MIRAS phasing using iodide and xenon derivatives","journal":"Acta crystallographica. Section D, Biological crystallography","confidence":"High","confidence_rationale":"Tier 1 / Strong — independent crystal structure determination with novel phasing approach, consistent with companion structural study","pmids":["12136135"],"is_preprint":false},{"year":1996,"finding":"S100A3 is the predominant ~7 kDa protein of human hair cuticle, localized by immunofluorescence specifically to the cuticular layer of hair fibers.","method":"SDS-PAGE, S-carboxymethylation, reverse-phase HPLC peptide sequencing, immunoblotting, immunofluorescence microscopy","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct protein identification by peptide sequencing and immunolocalization, single lab with multiple orthogonal methods","pmids":["8672544"],"is_preprint":false},{"year":1999,"finding":"Ultrastructural localization by rapid-freezing immunoelectron microscopy demonstrated that S100A3 is specifically present in the endocuticle (inner portion adjacent to the cell membrane complex) and in the intermacrofibrillar matrix of cortex cells, spatially distinct from hair keratins.","method":"Rapid-freezing immunocytochemistry, electron microscopy, double immunolabeling","journal":"The journal of histochemistry and cytochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ultrastructural localization with double-labeling controls, single lab","pmids":["10082754"],"is_preprint":false},{"year":2002,"finding":"Native S100A3 purified from human hair cuticle carries an N-terminal acetyl group replacing the initiator methionine, as determined by tandem mass spectrometry; cuticle S100A3 has a slightly lower isoelectric point than recombinant protein.","method":"Anion-exchange chromatography purification, 2D gel electrophoresis, tandem mass spectrometry (LC-MS/MS)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct MS identification of PTM on native protein, single lab","pmids":["12470658"],"is_preprint":false},{"year":2007,"finding":"More than half of the arginine residues of native hair cuticle S100A3 are converted to citrullines by peptidylarginine deiminases (PADs); PAD3 specifically citrullinates only Arg-51, whereas PAD1 and PAD2 convert all 4 arginines. Citrullination of Arg-51 (or its R51A substitution) promotes assembly of a stable globular homotetramer with increased Ca2+ binding capacity.","method":"2D PAGE-Western blot with citrulline antibody, confocal immunofluorescence co-localization, recombinant PAD enzymatic assays, gel filtration, fluorescent Ca2+ titration, site-directed mutagenesis (R51A)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (enzymatic assay, mutagenesis, structural analysis, fluorimetry), co-localization with PAD3 in native tissue, independently supported by subsequent structural studies","pmids":["18083705"],"is_preprint":false},{"year":2011,"finding":"Refined crystal structures of S100A3 at 1.40–2.15 Å identified two intramolecular disulfide bridges: SS1 (Cys30–Cys68) and SS2 (Cys99–Cys81). Mutagenesis showed SS1 disruption (C30A+C68A) abolishes Ca2+ binding and retards PAD3 citrullination of Arg51, while SS2 disruption increases both Ca2+ affinity and PAD3 reactivity; a tetrahedral Zn2+ coordination by (Cys)3His is proposed compatible with SS2.","method":"X-ray crystallography (1.40–2.15 Å), site-directed mutagenesis, in vitro PAD3 citrullination assay, Ca2+ binding assay","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structures combined with functional mutagenesis validating structural findings, multiple orthogonal methods","pmids":["21377473"],"is_preprint":false},{"year":2020,"finding":"The R51Q mutant of S100A3 is an optimal model of citrullinated S100A3: it forms a tetramer in the presence of Ca2+, with Ca2+-binding properties similar to citrullinated WT. SEC-SAXS showed that the R51Q tetramer expands ~1.5-fold in radius of gyration upon Ca2+/Zn2+ addition, whereas WT undergoes nonspecific aggregation, demonstrating that citrullination of Arg51 is essential for stabilizing the Ca2+/Zn2+-bound tetrameric state.","method":"Size exclusion chromatography, Trp fluorescence Ca2+ titration, SEC-small-angle X-ray scattering (SAXS), dynamic light scattering, site-directed mutagenesis","journal":"ACS omega","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution with multiple orthogonal structural methods (SAXS, SEC, DLS, fluorimetry), single lab","pmids":["32149230"],"is_preprint":false},{"year":2018,"finding":"S100A3 directly interacts with the ligand-binding domain of RARα (with residue I396 playing a crucial role) constitutively and independently of ATRA. This interaction stabilizes RARα protein levels; S100A3 knockdown decreases RARα amounts in breast and lung cancer cells, inducing ATRA resistance, while in APL/AML cells S100A3 knockdown reduces both RARα and PML-RARα and paradoxically increases ATRA-induced differentiation.","method":"Co-immunoprecipitation (RARα interactome), direct binding assays, site-directed mutagenesis (I396), siRNA knockdown, protein stability assays, proliferation/differentiation assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction mapped to specific domain residue, knockdown with defined molecular and cellular phenotypes, single lab","pmids":["30532072"],"is_preprint":false},{"year":2014,"finding":"S100A3 inhibition in castration-resistant prostate cancer cells via shRNA reduces cell viability through apoptosis, decreases invasiveness, and downregulates MMP-2 and/or MMP-9 expression; in vivo, S100A3 shRNA-transfected xenografts show markedly reduced tumor growth.","method":"siRNA/shRNA knockdown, Cell Counting Kit-8 viability assay, flow cytometry (apoptosis), transwell migration/invasion assay, RT-PCR, gelatin zymography, xenograft mouse model","journal":"Urology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with multiple cellular and in vivo readouts, MMP regulation as molecular mechanism, single lab","pmids":["25440760"],"is_preprint":false},{"year":2015,"finding":"In vivo blockade of S100A3 with a specific antibody in mice delays hair follicle entry into anagen phase, decreases hair elongation, and reduces follicle number in subcutis, with corresponding downregulation of hair growth induction genes; S100A3 localizes to hair shafts during anagen and sebaceous glands during telogen.","method":"Subcutaneous antibody injection in depilation-induced hair growth mouse model, immunohistochemistry, gene expression microarray, in vivo hair growth assessment","journal":"Genetics and molecular research : GMR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with defined cellular phenotype and gene expression changes, single lab","pmids":["26535667"],"is_preprint":false},{"year":2017,"finding":"ALOX12 inhibition (by hinokitiol, esculetin, quercetin, or arachidonic acid) promotes S100A3 citrullination in SW480 cells and isolated human hair follicles, mediated through upregulation of HBEGF which regulates PADI gene expression.","method":"Cell-based citrullination assays, microarray gene expression analysis, isolated human hair follicle culture, recombinant HBEGF treatment, ALOX12 inhibitor treatment","journal":"Biological & pharmaceutical bulletin","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pathway placement via pharmacological inhibition and correlative gene expression, indirect evidence, single lab","pmids":["28381806"],"is_preprint":false},{"year":2019,"finding":"Co-inheritance of a hypomorphic variant in S100A3 and a truncating mutation in S100A13 (autosomal recessive digenic inheritance) causes familial pulmonary fibrosis associated with significantly reduced S100A3 and S100A13 expression, aberrant intracellular Ca2+ homeostasis, mitochondrial dysregulation, and altered ECM component expression in patient-derived fibroblasts.","method":"Whole blood/tissue molecular genetic investigation, patient-derived fibroblast analysis, calcium homeostasis assays, mitochondrial function assays, gene expression analysis","journal":"The European respiratory journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in human patients with functional cellular phenotyping of patient-derived cells, digenic mechanism with multiple phenotypic readouts","pmids":["31073086"],"is_preprint":false},{"year":2023,"finding":"Transfection of wild-type S100A3 (and S100A13) into patient-derived pulmonary fibrosis cells, or extracellular treatment with recombinant S100A3/S100A13 proteins, reverses increased mitochondrial mass, mitochondrial hyperpolarization, aberrant receptor-mediated Ca2+ signaling, and elevated inflammatory mediator secretion caused by the mutant proteins.","method":"Cell transfection with WT and mutant constructs, recombinant protein treatment, calcium signaling assays, mitochondrial function assays (mass and membrane potential), inflammatory mediator measurement","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — rescue experiment with WT protein providing direct causal evidence for S100A3 role in Ca2+ homeostasis and mitochondrial function, single lab","pmids":["38099297"],"is_preprint":false},{"year":2023,"finding":"S100A3 upregulation in HBV-producing HepG2.2.15 cells increases HBV DNA, HBsAg, and HBeAg levels, while S100A3 knockdown significantly reduces these viral markers, establishing S100A3 as a host factor that promotes HBV replication/antigen production.","method":"siRNA knockdown, S100A3 overexpression, HBsAg/HBeAg ELISA, HBV DNA quantification, rAAV-HBV1.3 mouse model","journal":"Biomedicine & pharmacotherapy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — gain- and loss-of-function with viral replication readouts but no molecular mechanism elucidated, single lab","pmids":["37207431"],"is_preprint":false}],"current_model":"S100A3 is a cysteine-rich, EF-hand Ca2+/Zn2+-binding protein that exists as a non-covalent dimer stabilized by two intramolecular disulfide bridges (Cys30–Cys68 and Cys81–Cys99); it binds Zn2+ with high affinity via a (Cys)3His tetrahedral site and Ca2+ with low affinity (Kd ~4 mM), but undergoes specific citrullination of Arg-51 by PAD3 in hair cuticular cells—a modification essential for assembling a stable globular homotetramer with enhanced Ca2+-binding capacity that supports hair cuticle maturation; in cancer cell contexts, S100A3 directly binds the ligand-binding domain of RARα to regulate its stability and ATRA-dependent signaling, and promotes cell survival/invasion through MMP regulation, while mutations reducing S100A3 expression disrupt intracellular Ca2+ homeostasis and mitochondrial function."},"narrative":{"mechanistic_narrative":"S100A3 is a cysteine-rich EF-hand protein of the S100 family encoded in the chromosome 1q21 S100 cluster, distinguished from its relatives by an unusually high cysteine content [PMID:8341667]. It is a non-covalent dimer that binds Ca2+ with low affinity (Kd ~4 mM) and Zn2+ with high affinity through thiolate-bridged metal clusters, including a (Cys)3His coordination site [PMID:9920417, PMID:21377473]. High-resolution crystal structures show that the C-terminal canonical EF-hand is distorted in the apo state and that Zn2+ binding drives large conformational changes at the hydrophobic dimer interface; two intramolecular disulfide bridges, Cys30–Cys68 (SS1) and Cys81–Cys99 (SS2), gate both Ca2+ binding and citrullination, with SS1 disruption abolishing Ca2+ binding and SS2 disruption increasing Ca2+ affinity [PMID:12045193, PMID:21377473]. The protein is the predominant ~7 kDa component of human hair cuticle, localizing to the endocuticle and intermacrofibrillar matrix [PMID:8672544, PMID:10082754], where PAD3 specifically citrullinates Arg-51; this single modification is essential for assembling a stable Ca2+/Zn2+-bound globular homotetramer that expands upon metal binding rather than aggregating, supporting hair cuticle and follicle maturation [PMID:18083705, PMID:32149230, PMID:26535667]. Beyond hair, S100A3 directly binds the ligand-binding domain of RARα (via residue I396) to stabilize RARα protein and modulate ATRA signaling in cancer cells, and its loss reduces viability and invasion in prostate cancer through downregulation of MMP-2/MMP-9 [PMID:30532072, PMID:25440760]. Digenic co-inheritance of a hypomorphic S100A3 variant with a truncating S100A13 mutation causes familial pulmonary fibrosis, in which reduced S100A3 disrupts intracellular Ca2+ homeostasis and mitochondrial function—defects reversed by restoring wild-type protein [PMID:31073086, PMID:38099297].","teleology":[{"year":1993,"claim":"Established S100A3 as a distinct S100 family member, defining its genomic context and its hallmark high cysteine content that would later prove central to its metal chemistry.","evidence":"Pulsed-field gel electrophoresis and genomic sequencing mapping the 1q21 S100 cluster","pmids":["8341667"],"confidence":"Medium","gaps":["No functional or biochemical activity assigned","Tissue distribution and physiological role unknown at this stage"]},{"year":1996,"claim":"Identified the native physiological context of S100A3 by showing it is the dominant protein of the hair cuticle, anchoring later structural and PTM work to a specific tissue.","evidence":"Peptide sequencing, immunoblotting and immunofluorescence on human hair fibers","pmids":["8672544"],"confidence":"Medium","gaps":["Molecular function within the cuticle not defined","Did not address metal binding or oligomeric state"]},{"year":1999,"claim":"Refined the localization to the endocuticle and intermacrofibrillar matrix, placing S100A3 spatially distinct from keratins and implying a non-structural-fiber role.","evidence":"Rapid-freezing immunoelectron microscopy with double immunolabeling","pmids":["10082754"],"confidence":"Medium","gaps":["Functional consequence of this localization unresolved","No interacting partners identified"]},{"year":1998,"claim":"Defined S100A3's unusual metal-binding behavior—weak Ca2+ but high-affinity Zn2+ via cysteine thiolate clusters—reframing it as a Zn2+-centered rather than canonical Ca2+ sensor.","evidence":"Anaerobic recombinant purification with spectrophotometric metal titration, SEC and CD","pmids":["9920417"],"confidence":"Medium","gaps":["Atomic coordination geometry not yet resolved","Physiological metal occupancy in vivo unknown"]},{"year":2002,"claim":"Provided the first atomic structures, explaining weak Ca2+ binding through a distorted C-terminal EF-hand and revealing a C-terminal Zn2+ site and Zn2+-induced interface rearrangement.","evidence":"X-ray crystallography of apo-S100A3 (1.7 Å and MIRAS-phased structures) with SEC/CD","pmids":["12045193","12136135"],"confidence":"High","gaps":["Metal-bound structure not captured","Functional oligomeric assembly not yet linked to structure"]},{"year":2002,"claim":"Characterized a native N-terminal acetylation PTM, distinguishing tissue-derived S100A3 from recombinant protein and flagging post-translational regulation.","evidence":"2D gel electrophoresis and LC-MS/MS on cuticle-purified protein","pmids":["12470658"],"confidence":"Medium","gaps":["Functional impact of N-acetylation untested","Did not address citrullination"]},{"year":2007,"claim":"Identified PAD3-specific citrullination of Arg-51 as the key activating modification that converts S100A3 into a stable tetramer with enhanced Ca2+ binding, linking an enzyme to functional assembly in hair.","evidence":"PAD enzymatic assays, citrulline-antibody Western blot, R51A mutagenesis, gel filtration and Ca2+ fluorimetry with PAD3 co-localization in tissue","pmids":["18083705"],"confidence":"High","gaps":["Structural basis of tetramerization not resolved here","Downstream cuticle assembly partners unknown"]},{"year":2011,"claim":"Mapped two intramolecular disulfide bridges and showed they oppositely gate Ca2+ binding and PAD3 reactivity, mechanistically coupling redox state to metal binding and citrullination.","evidence":"High-resolution crystallography (1.40–2.15 Å) with site-directed mutagenesis, PAD3 and Ca2+ binding assays","pmids":["21377473"],"confidence":"High","gaps":["In vivo redox regulation of the bridges untested","Citrullinated-state structure not obtained"]},{"year":2020,"claim":"Used the R51Q citrullination mimic to demonstrate directly that Arg-51 modification is required for an ordered Ca2+/Zn2+-bound tetramer that expands rather than aggregates, resolving the assembly mechanism.","evidence":"SEC-SAXS, DLS, Trp-fluorescence Ca2+ titration on R51Q versus WT","pmids":["32149230"],"confidence":"High","gaps":["High-resolution tetramer structure still lacking","Functional output of the tetramer in the cuticle not directly tested"]},{"year":2015,"claim":"Demonstrated a physiological requirement for S100A3 in hair growth, with antibody blockade delaying anagen entry and reducing follicle number, connecting the cuticle protein to follicle cycling.","evidence":"Subcutaneous antibody blockade in a depilation-induced mouse hair model with IHC and expression microarray","pmids":["26535667"],"confidence":"Medium","gaps":["Mechanism downstream of blockade unclear","Antibody specificity/off-target effects not fully excluded"]},{"year":2018,"claim":"Revealed an unexpected cancer-related function by showing S100A3 binds the RARα ligand-binding domain to stabilize the receptor and tune ATRA responses, extending its role beyond hair.","evidence":"Co-IP interactome, I396 mutagenesis, siRNA knockdown and protein stability/differentiation assays in cancer cell lines","pmids":["30532072"],"confidence":"Medium","gaps":["Whether metal binding/citrullination modulates RARα interaction unknown","Single-lab finding without reciprocal in vivo validation"]},{"year":2014,"claim":"Linked S100A3 to tumor cell survival and invasion through MMP regulation, identifying a pro-tumorigenic loss-of-function phenotype in prostate cancer.","evidence":"shRNA knockdown with viability, apoptosis, invasion, zymography and xenograft assays","pmids":["25440760"],"confidence":"Medium","gaps":["Direct molecular link between S100A3 and MMP transcription not established","Relationship to RARα pathway not explored"]},{"year":2019,"claim":"Connected S100A3 to human disease, showing digenic co-inheritance with S100A13 causes familial pulmonary fibrosis with Ca2+ and mitochondrial defects in patient fibroblasts.","evidence":"Molecular genetics with patient-derived fibroblast Ca2+, mitochondrial and expression assays","pmids":["31073086"],"confidence":"Medium","gaps":["Mechanism coupling S100A3 loss to mitochondrial dysfunction undefined","Relative contribution of S100A3 versus S100A13 not separated"]},{"year":2023,"claim":"Established causality for the fibrosis phenotype by showing wild-type S100A3 (intracellular or recombinant extracellular) rescues Ca2+ signaling, mitochondrial mass/potential and inflammatory output.","evidence":"WT/mutant transfection and recombinant protein rescue in patient-derived fibrosis cells","pmids":["38099297"],"confidence":"Medium","gaps":["Molecular receptor/effector for extracellular S100A3 unknown","Link to citrullination/tetramerization chemistry untested"]},{"year":2017,"claim":"Placed S100A3 citrullination within an ALOX12–HBEGF–PADI regulatory axis, suggesting upstream pharmacological control of its activating modification.","evidence":"Pharmacological ALOX12 inhibition and correlative microarray in SW480 cells and human hair follicles with HBEGF treatment","pmids":["28381806"],"confidence":"Low","gaps":["Indirect, correlative pathway placement without direct enzymatic linkage","Effect on S100A3 function not measured"]},{"year":2023,"claim":"Implicated S100A3 as a host factor supporting HBV replication, broadening its potential disease relevance.","evidence":"siRNA knockdown and overexpression with HBV DNA/antigen quantification and an rAAV-HBV mouse model","pmids":["37207431"],"confidence":"Low","gaps":["No molecular mechanism for the HBV effect established","Single-lab, mechanism-free correlation"]},{"year":null,"claim":"How S100A3's metal-binding/citrullination-driven tetramerization chemistry mechanistically connects to its disparate roles in RARα stabilization, MMP-driven invasion, and mitochondrial/Ca2+ homeostasis remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified mechanism linking the structural chemistry to cancer and fibrosis functions","Extracellular receptor/effector for secreted S100A3 unidentified","Whether citrullination occurs in non-hair contexts unknown"]}],"mechanism_profile":{"molecular_activity":[],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[14,15]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[4,5,15]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[14,15]}],"complexes":["S100A3 homotetramer (citrullinated, Ca2+/Zn2+-bound)"],"partners":["RARA","PADI3","S100A13"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P33764","full_name":"Protein S100-A3","aliases":["Protein S-100E","S100 calcium-binding protein A3"],"length_aa":101,"mass_kda":11.7,"function":"Binds both calcium and zinc. May be involved in calcium-dependent cuticle cell differentiation, hair shaft and hair cuticular barrier formation","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P33764/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/S100A3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/S100A3","total_profiled":1310},"omim":[{"mim_id":"176992","title":"S100 CALCIUM-BINDING PROTEIN A3; S100A3","url":"https://www.omim.org/entry/176992"},{"mim_id":"176991","title":"S100 CALCIUM-BINDING PROTEIN A5; S100A5","url":"https://www.omim.org/entry/176991"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Cytosol","reliability":"Enhanced"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"skin 1","ntpm":98.8}],"url":"https://www.proteinatlas.org/search/S100A3"},"hgnc":{"alias_symbol":[],"prev_symbol":["S100E"]},"alphafold":{"accession":"P33764","domains":[{"cath_id":"1.10.238.10","chopping":"3-79","consensus_level":"high","plddt":88.9034,"start":3,"end":79}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P33764","model_url":"https://alphafold.ebi.ac.uk/files/AF-P33764-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P33764-F1-predicted_aligned_error_v6.png","plddt_mean":81.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=S100A3","jax_strain_url":"https://www.jax.org/strain/search?query=S100A3"},"sequence":{"accession":"P33764","fasta_url":"https://rest.uniprot.org/uniprotkb/P33764.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P33764/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P33764"}},"corpus_meta":[{"pmid":"8341667","id":"PMC_8341667","title":"Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8341667","citation_count":177,"is_preprint":false},{"pmid":"18083705","id":"PMC_18083705","title":"Specific citrullination causes assembly of a globular S100A3 homotetramer: a putative Ca2+ modulator matures human hair cuticle.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18083705","citation_count":55,"is_preprint":false},{"pmid":"21664410","id":"PMC_21664410","title":"S100 and S100 fused-type protein families in epidermal maturation with special focus on S100A3 in mammalian hair cuticles.","date":"2011","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/21664410","citation_count":53,"is_preprint":false},{"pmid":"12045193","id":"PMC_12045193","title":"The crystal structure of metal-free human EF-hand protein S100A3 at 1.7-A resolution.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12045193","citation_count":38,"is_preprint":false},{"pmid":"8672544","id":"PMC_8672544","title":"Highly-expressed S100A3, a calcium-binding protein, in human hair cuticle.","date":"1996","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8672544","citation_count":36,"is_preprint":false},{"pmid":"10082754","id":"PMC_10082754","title":"Ultrastructural localization of S100A3, a cysteine-rich, calcium binding protein, in human scalp hair shafts revealed by rapid-freezing immunocytochemistry.","date":"1999","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/10082754","citation_count":31,"is_preprint":false},{"pmid":"9920417","id":"PMC_9920417","title":"Probing the structure of the human Ca2+- and Zn2+-binding protein S100A3: spectroscopic investigations of its transition metal ion complexes, and three-dimensional structural model.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9920417","citation_count":28,"is_preprint":false},{"pmid":"28588665","id":"PMC_28588665","title":"Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate.","date":"2017","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28588665","citation_count":25,"is_preprint":false},{"pmid":"25440760","id":"PMC_25440760","title":"S100A3 suppression inhibits in vitro and in vivo tumor growth and invasion of human castration-resistant prostate cancer cells.","date":"2014","source":"Urology","url":"https://pubmed.ncbi.nlm.nih.gov/25440760","citation_count":22,"is_preprint":false},{"pmid":"30532072","id":"PMC_30532072","title":"S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30532072","citation_count":21,"is_preprint":false},{"pmid":"24255681","id":"PMC_24255681","title":"Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinate.","date":"2013","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24255681","citation_count":20,"is_preprint":false},{"pmid":"21377473","id":"PMC_21377473","title":"Refined crystal structures of human Ca(2+)/Zn(2+)-binding S100A3 protein characterized by two disulfide bridges.","date":"2011","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21377473","citation_count":19,"is_preprint":false},{"pmid":"15727645","id":"PMC_15727645","title":"Aberrantly differentiated cells in benign pilomatrixoma reflect the normal hair follicle: immunohistochemical analysis of Ca-binding S100A2, S100A3 and S100A6 proteins.","date":"2005","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15727645","citation_count":18,"is_preprint":false},{"pmid":"12136135","id":"PMC_12136135","title":"Metal-free MIRAS phasing: structure of apo-S100A3.","date":"2002","source":"Acta crystallographica. Section D, Biological crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/12136135","citation_count":18,"is_preprint":false},{"pmid":"31059116","id":"PMC_31059116","title":"Semaphorin 3A (SEMA3A), protocadherin 9 (PCdh9), and S100 calcium binding protein A3 (S100A3) as potential biomarkers of carcinogenesis and chemoresistance of different neoplasms, including ovarian cancer - review of literature.","date":"2019","source":"Ginekologia polska","url":"https://pubmed.ncbi.nlm.nih.gov/31059116","citation_count":17,"is_preprint":false},{"pmid":"12470658","id":"PMC_12470658","title":"Characterization of the cysteine-rich calcium-binding S100A3 protein from human hair cuticles.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12470658","citation_count":16,"is_preprint":false},{"pmid":"31073086","id":"PMC_31073086","title":"An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13.","date":"2019","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/31073086","citation_count":15,"is_preprint":false},{"pmid":"16130044","id":"PMC_16130044","title":"Dissimilar effect of perming and bleaching treatments on cuticles: advanced hair damage model based on elution and oxidation of S100A3 protein.","date":"2005","source":"Journal of cosmetic science","url":"https://pubmed.ncbi.nlm.nih.gov/16130044","citation_count":11,"is_preprint":false},{"pmid":"26710891","id":"PMC_26710891","title":"Age-dependent damage of hair cuticle: contribution of S100A3 protein and its citrullination.","date":"2015","source":"Journal of cosmetic dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/26710891","citation_count":8,"is_preprint":false},{"pmid":"31302167","id":"PMC_31302167","title":"Evolution of S100A3 and PAD3, two important genes for mammalian hair.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31302167","citation_count":7,"is_preprint":false},{"pmid":"32149230","id":"PMC_32149230","title":"Optimal Mutant Model of Human S100A3 Protein Citrullinated at Arg51 by Peptidylarginine Deiminase Type III and Its Solution Structural Properties.","date":"2020","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/32149230","citation_count":7,"is_preprint":false},{"pmid":"26535667","id":"PMC_26535667","title":"Blockade of S100A3 activity inhibits murine hair growth.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26535667","citation_count":6,"is_preprint":false},{"pmid":"23296605","id":"PMC_23296605","title":"Purification and characterization of the human cysteine-rich S100A3 protein and its pseudo citrullinated forms expressed in insect cells.","date":"2013","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/23296605","citation_count":6,"is_preprint":false},{"pmid":"37207431","id":"PMC_37207431","title":"Transcriptomics based identification of S100A3 as the key anti-hepatitis B virus factor of 16F16.","date":"2023","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/37207431","citation_count":5,"is_preprint":false},{"pmid":"28381806","id":"PMC_28381806","title":"Arachidonate 12-Lipoxygenase Inhibitors Promote S100A3 Citrullination in Cultured SW480 Cells and Isolated Hair Follicles.","date":"2017","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/28381806","citation_count":4,"is_preprint":false},{"pmid":"38099297","id":"PMC_38099297","title":"Wild-type S100A3 and S100A13 restore calcium homeostasis and mitigate mitochondrial dysregulation in pulmonary fibrosis patient-derived cells.","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/38099297","citation_count":3,"is_preprint":false},{"pmid":"37787841","id":"PMC_37787841","title":"Pseudogenization of the Hair-Related Genes PADI3 and S100A3 in Cetaceans and Hippopotamus amphibius.","date":"2023","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/37787841","citation_count":2,"is_preprint":false},{"pmid":"40046022","id":"PMC_40046022","title":"Risk associated circulating biomarkers S100A3 identified in congenital heart disease-associated pulmonary arterial hypertension.","date":"2025","source":"Intractable & rare diseases research","url":"https://pubmed.ncbi.nlm.nih.gov/40046022","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14978,"output_tokens":4338,"usd":0.055002,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12375,"output_tokens":4613,"usd":0.0886,"stage2_stop_reason":"end_turn"},"total_usd":0.143602,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"S100A3 (S100E) is a cysteine-rich calcium-binding protein encoded within a tight cluster of six S100 genes on human chromosome 1q21, distinguishing it from other S100 family members by its unusually high cysteine content.\",\n      \"method\": \"Pulsed-field gel electrophoresis, genomic sequencing, chromosomal mapping\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct genomic/sequencing characterization identifying unique structural feature, single study with clear experimental evidence\",\n      \"pmids\": [\"8341667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"S100A3 exists as a non-covalently bound dimer and binds Ca2+ with low affinity (Kd ~4 mM) and Zn2+ with high affinity via its cysteine residues, forming dinuclear thiolate-bridged metal clusters involving (Cys)4 and (Cys)3(His) coordination sites analogous to zinc finger proteins.\",\n      \"method\": \"Anaerobic recombinant protein purification, spectrophotometric metal titration, size exclusion chromatography, CD spectroscopy\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro biochemical characterization with multiple spectroscopic methods, single lab\",\n      \"pmids\": [\"9920417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Crystal structure of metal-free S100A3 at 1.7 Å resolution revealed a large distortion of the C-terminal canonical EF-hand that likely abolishes Ca2+ binding, and identified a putative Zn2+-binding site in the C-terminus involving Cys and His residues; Zn2+ binding induces large conformational changes perturbing the hydrophobic dimer interface.\",\n      \"method\": \"X-ray crystallography (1.7 Å), size exclusion chromatography, CD spectroscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with functional validation by SEC and CD, replicated by subsequent structural studies\",\n      \"pmids\": [\"12045193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Metal-free apo-S100A3 crystal structure confirmed the overall fold resembles metal-free S100B and S100A6, with well-ordered EF-hand loops; in the N-terminal pseudo-EF-hand loop a water molecule occupies the Ca2+ position, and the C-terminal canonical EF-hand shows extended conformation distinct from metal-bound S100 structures.\",\n      \"method\": \"X-ray crystallography solved by MIRAS phasing using iodide and xenon derivatives\",\n      \"journal\": \"Acta crystallographica. Section D, Biological crystallography\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — independent crystal structure determination with novel phasing approach, consistent with companion structural study\",\n      \"pmids\": [\"12136135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"S100A3 is the predominant ~7 kDa protein of human hair cuticle, localized by immunofluorescence specifically to the cuticular layer of hair fibers.\",\n      \"method\": \"SDS-PAGE, S-carboxymethylation, reverse-phase HPLC peptide sequencing, immunoblotting, immunofluorescence microscopy\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein identification by peptide sequencing and immunolocalization, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"8672544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Ultrastructural localization by rapid-freezing immunoelectron microscopy demonstrated that S100A3 is specifically present in the endocuticle (inner portion adjacent to the cell membrane complex) and in the intermacrofibrillar matrix of cortex cells, spatially distinct from hair keratins.\",\n      \"method\": \"Rapid-freezing immunocytochemistry, electron microscopy, double immunolabeling\",\n      \"journal\": \"The journal of histochemistry and cytochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ultrastructural localization with double-labeling controls, single lab\",\n      \"pmids\": [\"10082754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Native S100A3 purified from human hair cuticle carries an N-terminal acetyl group replacing the initiator methionine, as determined by tandem mass spectrometry; cuticle S100A3 has a slightly lower isoelectric point than recombinant protein.\",\n      \"method\": \"Anion-exchange chromatography purification, 2D gel electrophoresis, tandem mass spectrometry (LC-MS/MS)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct MS identification of PTM on native protein, single lab\",\n      \"pmids\": [\"12470658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"More than half of the arginine residues of native hair cuticle S100A3 are converted to citrullines by peptidylarginine deiminases (PADs); PAD3 specifically citrullinates only Arg-51, whereas PAD1 and PAD2 convert all 4 arginines. Citrullination of Arg-51 (or its R51A substitution) promotes assembly of a stable globular homotetramer with increased Ca2+ binding capacity.\",\n      \"method\": \"2D PAGE-Western blot with citrulline antibody, confocal immunofluorescence co-localization, recombinant PAD enzymatic assays, gel filtration, fluorescent Ca2+ titration, site-directed mutagenesis (R51A)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (enzymatic assay, mutagenesis, structural analysis, fluorimetry), co-localization with PAD3 in native tissue, independently supported by subsequent structural studies\",\n      \"pmids\": [\"18083705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Refined crystal structures of S100A3 at 1.40–2.15 Å identified two intramolecular disulfide bridges: SS1 (Cys30–Cys68) and SS2 (Cys99–Cys81). Mutagenesis showed SS1 disruption (C30A+C68A) abolishes Ca2+ binding and retards PAD3 citrullination of Arg51, while SS2 disruption increases both Ca2+ affinity and PAD3 reactivity; a tetrahedral Zn2+ coordination by (Cys)3His is proposed compatible with SS2.\",\n      \"method\": \"X-ray crystallography (1.40–2.15 Å), site-directed mutagenesis, in vitro PAD3 citrullination assay, Ca2+ binding assay\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structures combined with functional mutagenesis validating structural findings, multiple orthogonal methods\",\n      \"pmids\": [\"21377473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The R51Q mutant of S100A3 is an optimal model of citrullinated S100A3: it forms a tetramer in the presence of Ca2+, with Ca2+-binding properties similar to citrullinated WT. SEC-SAXS showed that the R51Q tetramer expands ~1.5-fold in radius of gyration upon Ca2+/Zn2+ addition, whereas WT undergoes nonspecific aggregation, demonstrating that citrullination of Arg51 is essential for stabilizing the Ca2+/Zn2+-bound tetrameric state.\",\n      \"method\": \"Size exclusion chromatography, Trp fluorescence Ca2+ titration, SEC-small-angle X-ray scattering (SAXS), dynamic light scattering, site-directed mutagenesis\",\n      \"journal\": \"ACS omega\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution with multiple orthogonal structural methods (SAXS, SEC, DLS, fluorimetry), single lab\",\n      \"pmids\": [\"32149230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"S100A3 directly interacts with the ligand-binding domain of RARα (with residue I396 playing a crucial role) constitutively and independently of ATRA. This interaction stabilizes RARα protein levels; S100A3 knockdown decreases RARα amounts in breast and lung cancer cells, inducing ATRA resistance, while in APL/AML cells S100A3 knockdown reduces both RARα and PML-RARα and paradoxically increases ATRA-induced differentiation.\",\n      \"method\": \"Co-immunoprecipitation (RARα interactome), direct binding assays, site-directed mutagenesis (I396), siRNA knockdown, protein stability assays, proliferation/differentiation assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction mapped to specific domain residue, knockdown with defined molecular and cellular phenotypes, single lab\",\n      \"pmids\": [\"30532072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"S100A3 inhibition in castration-resistant prostate cancer cells via shRNA reduces cell viability through apoptosis, decreases invasiveness, and downregulates MMP-2 and/or MMP-9 expression; in vivo, S100A3 shRNA-transfected xenografts show markedly reduced tumor growth.\",\n      \"method\": \"siRNA/shRNA knockdown, Cell Counting Kit-8 viability assay, flow cytometry (apoptosis), transwell migration/invasion assay, RT-PCR, gelatin zymography, xenograft mouse model\",\n      \"journal\": \"Urology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with multiple cellular and in vivo readouts, MMP regulation as molecular mechanism, single lab\",\n      \"pmids\": [\"25440760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In vivo blockade of S100A3 with a specific antibody in mice delays hair follicle entry into anagen phase, decreases hair elongation, and reduces follicle number in subcutis, with corresponding downregulation of hair growth induction genes; S100A3 localizes to hair shafts during anagen and sebaceous glands during telogen.\",\n      \"method\": \"Subcutaneous antibody injection in depilation-induced hair growth mouse model, immunohistochemistry, gene expression microarray, in vivo hair growth assessment\",\n      \"journal\": \"Genetics and molecular research : GMR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with defined cellular phenotype and gene expression changes, single lab\",\n      \"pmids\": [\"26535667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ALOX12 inhibition (by hinokitiol, esculetin, quercetin, or arachidonic acid) promotes S100A3 citrullination in SW480 cells and isolated human hair follicles, mediated through upregulation of HBEGF which regulates PADI gene expression.\",\n      \"method\": \"Cell-based citrullination assays, microarray gene expression analysis, isolated human hair follicle culture, recombinant HBEGF treatment, ALOX12 inhibitor treatment\",\n      \"journal\": \"Biological & pharmaceutical bulletin\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pathway placement via pharmacological inhibition and correlative gene expression, indirect evidence, single lab\",\n      \"pmids\": [\"28381806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Co-inheritance of a hypomorphic variant in S100A3 and a truncating mutation in S100A13 (autosomal recessive digenic inheritance) causes familial pulmonary fibrosis associated with significantly reduced S100A3 and S100A13 expression, aberrant intracellular Ca2+ homeostasis, mitochondrial dysregulation, and altered ECM component expression in patient-derived fibroblasts.\",\n      \"method\": \"Whole blood/tissue molecular genetic investigation, patient-derived fibroblast analysis, calcium homeostasis assays, mitochondrial function assays, gene expression analysis\",\n      \"journal\": \"The European respiratory journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in human patients with functional cellular phenotyping of patient-derived cells, digenic mechanism with multiple phenotypic readouts\",\n      \"pmids\": [\"31073086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Transfection of wild-type S100A3 (and S100A13) into patient-derived pulmonary fibrosis cells, or extracellular treatment with recombinant S100A3/S100A13 proteins, reverses increased mitochondrial mass, mitochondrial hyperpolarization, aberrant receptor-mediated Ca2+ signaling, and elevated inflammatory mediator secretion caused by the mutant proteins.\",\n      \"method\": \"Cell transfection with WT and mutant constructs, recombinant protein treatment, calcium signaling assays, mitochondrial function assays (mass and membrane potential), inflammatory mediator measurement\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — rescue experiment with WT protein providing direct causal evidence for S100A3 role in Ca2+ homeostasis and mitochondrial function, single lab\",\n      \"pmids\": [\"38099297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"S100A3 upregulation in HBV-producing HepG2.2.15 cells increases HBV DNA, HBsAg, and HBeAg levels, while S100A3 knockdown significantly reduces these viral markers, establishing S100A3 as a host factor that promotes HBV replication/antigen production.\",\n      \"method\": \"siRNA knockdown, S100A3 overexpression, HBsAg/HBeAg ELISA, HBV DNA quantification, rAAV-HBV1.3 mouse model\",\n      \"journal\": \"Biomedicine & pharmacotherapy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — gain- and loss-of-function with viral replication readouts but no molecular mechanism elucidated, single lab\",\n      \"pmids\": [\"37207431\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"S100A3 is a cysteine-rich, EF-hand Ca2+/Zn2+-binding protein that exists as a non-covalent dimer stabilized by two intramolecular disulfide bridges (Cys30–Cys68 and Cys81–Cys99); it binds Zn2+ with high affinity via a (Cys)3His tetrahedral site and Ca2+ with low affinity (Kd ~4 mM), but undergoes specific citrullination of Arg-51 by PAD3 in hair cuticular cells—a modification essential for assembling a stable globular homotetramer with enhanced Ca2+-binding capacity that supports hair cuticle maturation; in cancer cell contexts, S100A3 directly binds the ligand-binding domain of RARα to regulate its stability and ATRA-dependent signaling, and promotes cell survival/invasion through MMP regulation, while mutations reducing S100A3 expression disrupt intracellular Ca2+ homeostasis and mitochondrial function.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"S100A3 is a cysteine-rich EF-hand protein of the S100 family encoded in the chromosome 1q21 S100 cluster, distinguished from its relatives by an unusually high cysteine content [#0]. It is a non-covalent dimer that binds Ca2+ with low affinity (Kd ~4 mM) and Zn2+ with high affinity through thiolate-bridged metal clusters, including a (Cys)3His coordination site [#1, #8]. High-resolution crystal structures show that the C-terminal canonical EF-hand is distorted in the apo state and that Zn2+ binding drives large conformational changes at the hydrophobic dimer interface; two intramolecular disulfide bridges, Cys30–Cys68 (SS1) and Cys81–Cys99 (SS2), gate both Ca2+ binding and citrullination, with SS1 disruption abolishing Ca2+ binding and SS2 disruption increasing Ca2+ affinity [#2, #8]. The protein is the predominant ~7 kDa component of human hair cuticle, localizing to the endocuticle and intermacrofibrillar matrix [#4, #5], where PAD3 specifically citrullinates Arg-51; this single modification is essential for assembling a stable Ca2+/Zn2+-bound globular homotetramer that expands upon metal binding rather than aggregating, supporting hair cuticle and follicle maturation [#7, #9, #12]. Beyond hair, S100A3 directly binds the ligand-binding domain of RARα (via residue I396) to stabilize RARα protein and modulate ATRA signaling in cancer cells, and its loss reduces viability and invasion in prostate cancer through downregulation of MMP-2/MMP-9 [#10, #11]. Digenic co-inheritance of a hypomorphic S100A3 variant with a truncating S100A13 mutation causes familial pulmonary fibrosis, in which reduced S100A3 disrupts intracellular Ca2+ homeostasis and mitochondrial function—defects reversed by restoring wild-type protein [#14, #15].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established S100A3 as a distinct S100 family member, defining its genomic context and its hallmark high cysteine content that would later prove central to its metal chemistry.\",\n      \"evidence\": \"Pulsed-field gel electrophoresis and genomic sequencing mapping the 1q21 S100 cluster\",\n      \"pmids\": [\"8341667\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional or biochemical activity assigned\", \"Tissue distribution and physiological role unknown at this stage\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified the native physiological context of S100A3 by showing it is the dominant protein of the hair cuticle, anchoring later structural and PTM work to a specific tissue.\",\n      \"evidence\": \"Peptide sequencing, immunoblotting and immunofluorescence on human hair fibers\",\n      \"pmids\": [\"8672544\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular function within the cuticle not defined\", \"Did not address metal binding or oligomeric state\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Refined the localization to the endocuticle and intermacrofibrillar matrix, placing S100A3 spatially distinct from keratins and implying a non-structural-fiber role.\",\n      \"evidence\": \"Rapid-freezing immunoelectron microscopy with double immunolabeling\",\n      \"pmids\": [\"10082754\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of this localization unresolved\", \"No interacting partners identified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined S100A3's unusual metal-binding behavior—weak Ca2+ but high-affinity Zn2+ via cysteine thiolate clusters—reframing it as a Zn2+-centered rather than canonical Ca2+ sensor.\",\n      \"evidence\": \"Anaerobic recombinant purification with spectrophotometric metal titration, SEC and CD\",\n      \"pmids\": [\"9920417\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Atomic coordination geometry not yet resolved\", \"Physiological metal occupancy in vivo unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Provided the first atomic structures, explaining weak Ca2+ binding through a distorted C-terminal EF-hand and revealing a C-terminal Zn2+ site and Zn2+-induced interface rearrangement.\",\n      \"evidence\": \"X-ray crystallography of apo-S100A3 (1.7 Å and MIRAS-phased structures) with SEC/CD\",\n      \"pmids\": [\"12045193\", \"12136135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Metal-bound structure not captured\", \"Functional oligomeric assembly not yet linked to structure\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Characterized a native N-terminal acetylation PTM, distinguishing tissue-derived S100A3 from recombinant protein and flagging post-translational regulation.\",\n      \"evidence\": \"2D gel electrophoresis and LC-MS/MS on cuticle-purified protein\",\n      \"pmids\": [\"12470658\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional impact of N-acetylation untested\", \"Did not address citrullination\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified PAD3-specific citrullination of Arg-51 as the key activating modification that converts S100A3 into a stable tetramer with enhanced Ca2+ binding, linking an enzyme to functional assembly in hair.\",\n      \"evidence\": \"PAD enzymatic assays, citrulline-antibody Western blot, R51A mutagenesis, gel filtration and Ca2+ fluorimetry with PAD3 co-localization in tissue\",\n      \"pmids\": [\"18083705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of tetramerization not resolved here\", \"Downstream cuticle assembly partners unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapped two intramolecular disulfide bridges and showed they oppositely gate Ca2+ binding and PAD3 reactivity, mechanistically coupling redox state to metal binding and citrullination.\",\n      \"evidence\": \"High-resolution crystallography (1.40–2.15 Å) with site-directed mutagenesis, PAD3 and Ca2+ binding assays\",\n      \"pmids\": [\"21377473\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo redox regulation of the bridges untested\", \"Citrullinated-state structure not obtained\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Used the R51Q citrullination mimic to demonstrate directly that Arg-51 modification is required for an ordered Ca2+/Zn2+-bound tetramer that expands rather than aggregates, resolving the assembly mechanism.\",\n      \"evidence\": \"SEC-SAXS, DLS, Trp-fluorescence Ca2+ titration on R51Q versus WT\",\n      \"pmids\": [\"32149230\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution tetramer structure still lacking\", \"Functional output of the tetramer in the cuticle not directly tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated a physiological requirement for S100A3 in hair growth, with antibody blockade delaying anagen entry and reducing follicle number, connecting the cuticle protein to follicle cycling.\",\n      \"evidence\": \"Subcutaneous antibody blockade in a depilation-induced mouse hair model with IHC and expression microarray\",\n      \"pmids\": [\"26535667\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism downstream of blockade unclear\", \"Antibody specificity/off-target effects not fully excluded\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed an unexpected cancer-related function by showing S100A3 binds the RARα ligand-binding domain to stabilize the receptor and tune ATRA responses, extending its role beyond hair.\",\n      \"evidence\": \"Co-IP interactome, I396 mutagenesis, siRNA knockdown and protein stability/differentiation assays in cancer cell lines\",\n      \"pmids\": [\"30532072\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether metal binding/citrullination modulates RARα interaction unknown\", \"Single-lab finding without reciprocal in vivo validation\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked S100A3 to tumor cell survival and invasion through MMP regulation, identifying a pro-tumorigenic loss-of-function phenotype in prostate cancer.\",\n      \"evidence\": \"shRNA knockdown with viability, apoptosis, invasion, zymography and xenograft assays\",\n      \"pmids\": [\"25440760\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular link between S100A3 and MMP transcription not established\", \"Relationship to RARα pathway not explored\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected S100A3 to human disease, showing digenic co-inheritance with S100A13 causes familial pulmonary fibrosis with Ca2+ and mitochondrial defects in patient fibroblasts.\",\n      \"evidence\": \"Molecular genetics with patient-derived fibroblast Ca2+, mitochondrial and expression assays\",\n      \"pmids\": [\"31073086\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism coupling S100A3 loss to mitochondrial dysfunction undefined\", \"Relative contribution of S100A3 versus S100A13 not separated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established causality for the fibrosis phenotype by showing wild-type S100A3 (intracellular or recombinant extracellular) rescues Ca2+ signaling, mitochondrial mass/potential and inflammatory output.\",\n      \"evidence\": \"WT/mutant transfection and recombinant protein rescue in patient-derived fibrosis cells\",\n      \"pmids\": [\"38099297\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular receptor/effector for extracellular S100A3 unknown\", \"Link to citrullination/tetramerization chemistry untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Placed S100A3 citrullination within an ALOX12–HBEGF–PADI regulatory axis, suggesting upstream pharmacological control of its activating modification.\",\n      \"evidence\": \"Pharmacological ALOX12 inhibition and correlative microarray in SW480 cells and human hair follicles with HBEGF treatment\",\n      \"pmids\": [\"28381806\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Indirect, correlative pathway placement without direct enzymatic linkage\", \"Effect on S100A3 function not measured\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Implicated S100A3 as a host factor supporting HBV replication, broadening its potential disease relevance.\",\n      \"evidence\": \"siRNA knockdown and overexpression with HBV DNA/antigen quantification and an rAAV-HBV mouse model\",\n      \"pmids\": [\"37207431\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No molecular mechanism for the HBV effect established\", \"Single-lab, mechanism-free correlation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How S100A3's metal-binding/citrullination-driven tetramerization chemistry mechanistically connects to its disparate roles in RARα stabilization, MMP-driven invasion, and mitochondrial/Ca2+ homeostasis remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified mechanism linking the structural chemistry to cancer and fibrosis functions\", \"Extracellular receptor/effector for secreted S100A3 unidentified\", \"Whether citrullination occurs in non-hair contexts unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0046872\", \"supporting_discovery_ids\": [1, 2, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [14, 15]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 5, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [14, 15]}\n    ],\n    \"complexes\": [\n      \"S100A3 homotetramer (citrullinated, Ca2+/Zn2+-bound)\"\n    ],\n    \"partners\": [\n      \"RARA\",\n      \"PADI3\",\n      \"S100A13\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}